Painkiller maker Oxford Cannabinoid Technologies debuts on London’s market May 21, 2021 Oxford Cannabinoid Technologies (OCT), which makes painkillers using cannabis components, has debuted on the London Stock Exchange this morning, offering £0.01 per share. The UK-based company, a pre-revenue pharmaceutical company developing cannabinoid-based prescription medicines, will begin trading on the capital’s main market at 8:00 this morning. Offering around 960m ordinary shares, OCT is set to [...]
Exclusive: Purity Hemp CEO on the UK’s fast-growing medical cannabis market February 24, 2021 After losing his sister to cancer and his best man to an opioid addiction, Canada-born, London-based Michael Walker felt he should explore alternative healthcare options so not to rely on Big Pharma. The former head of marketing at Heathrow Express left the advertising industry in 2016 to set up his own company, the Purity Wellness [...]
NBA star Chris Webber partners with asset manager to launch $100m cannabis impact fund February 17, 2021 NBA All-Star Chris Webber has partnered with JW Asset Management to launch a $100m private equity fund that will invest in companies led by entrepreneurs of colour working in the cannabis sector. The pair will collaborate to invest in underrepresented entrepreneurs in the cannabis industry and provide them with resources that will help them grow [...]
Cannabis rally goes up in smoke as shares plummet February 11, 2021 Cannabis stocks gave up its earlier highs on Thursday afternoon with leading US firms plummeting between 20 and 40 per cent. Cannabis stocks were among the most traded by German retail investors this morning, as a buying frenzy that has lit up the sector intensified. Tilray was the most traded stock on German trading platform [...]
The new Greenback: Why investors are getting high on medicinal cannabis firms February 8, 2021 Avihu Tamir is CEO of Kanabo For years, advocates of medicinal cannabis products have predicted that the industry is set to revolutionise healthcare – and make investors a tidy profit. That time may finally be coming. Take our firm, Kanabo Group, which became the first medicinal cannabis company to get approval from the Financial Conduct [...]
David Beckham-backed cannabis firm on course to become LSE’s first CBD listing February 4, 2021 UK-based Cellular Goods is seeking a listing on the London Stock Exchange, which would make them the LSE’s first pure-play CBD business
Will the FCA’s new plan mean cannabis companies can come in from the cold? September 24, 2020 How does the UK’s legal and financial establishment feel about the cannabis industry? The answer to that has changed significantly over the last few years, to the point that the Financial Conduct Authority (FCA) now contemplates their listing on the London Stock Exchange. But the legal rules around how to do that are far from [...]
The UK needs a science-led cannabis industry to help people get prescriptions September 10, 2020 Cannabis has been legal medically since November 2018, but it is still not easy to get a prescription. It is sadly the reality in the UK that the vast majority of cannabis is still supplied by the black market, and not by doctors. When you consider that some estimates suggest that about 1.3m people in [...]
Deep in the weeds: How to solve the legal problem of investing in cannabis January 20, 2020 A growing controversy exists which is being discussed with increased frequency by commentators concerning the restrictions on UK firms that wish to invest in the overseas cannabis industry. The controversy arises from the uncertainty regarding the legality of investing in a foreign company, based somewhere that cannabis is legal. In the UK, cannabis and synthetic [...]
The cannabis conundrum risks causing investors to be accused of money laundering November 27, 2019 The overseas legalised cannabis industry is growing fast — estimates suggest that the US cannabis industry will be worth over $75bn by 2030. Investment firms in the UK are keen to take full advantage of this growing market, but have found unexpected hurdles in their way. For UK-based investors, investing in this industry carries the [...]